< Dirk F Moore Ph.D. EOHSI Directory | EOHSI

Dirk F Moore Ph.D. » EOHSI Directory


Dirk F Moore Ph.D.

Associate Professor Rutgers University, School of Public HealthEOHSI – Environmental Epidemiology and Statistics
Work School of Public Health Room 215 683 Hoes Lane West Piscataway NJ 08854 Work Phone: 732-235-9748 Work Fax: 732-235-5464
Photo of Dirk F Moore Ph.D.

Biographical Info

Recent Publications

  1. Yang, Y, Karsli-Uzunbas, G, Poillet-Perez, L, Sawant, A, Hu, ZS, Zhao, Y, Moore, D, Hu, W, White, E. Autophagy promotes mammalian survival by suppressing oxidative stress and p53. Genes Dev. 2020;34 (9-10):688-700. doi: 10.1101/gad.335570.119. PubMed PMID:32193353 PubMed Central PMC7197357
  2. Tannous, A, Boonen, M, Zheng, H, Zhao, C, Germain, CJ, Moore, DF, Sleat, DE, Jadot, M, Lobel, P. Comparative Analysis of Quantitative Mass Spectrometric Methods for Subcellular Proteomics. J. Proteome Res. 2020;19 (4):1718-1730. doi: 10.1021/acs.jproteome.9b00862. PubMed PMID:32134668
  3. NeMoyer, RE, Pantin, E, Aisner, J, Jongco, R, Mellender, S, Chiricolo, A, Moore, DF, Langenfeld, J. Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy. J. Surg. Res. 2020;246 :19-25. doi: 10.1016/j.jss.2019.07.093. PubMed PMID:31550671
  4. Sleat, DE, Wiseman, JA, El-Banna, M, Zheng, H, Zhao, C, Soherwardy, A, Moore, DF, Lobel, P. Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome. Mol. Cell Proteomics. 2019;18 (11):2244-2261. doi: 10.1074/mcp.RA119.001587. PubMed PMID:31501224 PubMed Central PMC6823856
  5. Gupta, A, Khan, AJ, Yegya-Raman, N, Sayan, M, Ahlawat, S, Ohri, N, Goyal, S, Moore, DF, Eladoumikdachi, F, Toppmeyer, D et al.. 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost. Int. J. Radiat. Oncol. Biol. Phys. 2019;105 (2):267-274. doi: 10.1016/j.ijrobp.2019.05.063. PubMed PMID:31175905
  6. Na, B, Yu, X, Withers, T, Gilleran, J, Yao, M, Foo, TK, Chen, C, Moore, D, Lin, Y, Kimball, SD et al.. Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation. NPJ Breast Cancer. 2019;5 :14. doi: 10.1038/s41523-019-0110-1. PubMed PMID:30993195 PubMed Central PMC6465291
  7. Ali, ND, Donohue, K, Zandieh, S, Chen, C, Moore, D, Poplin, E, Shah, MM, Nosher, J, Gui, B, Jabbour, SK et al.. Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study. Am. J. Clin. Oncol. 2019;42 (6):512-518. doi: 10.1097/COC.0000000000000535. PubMed PMID:30973370 PubMed Central PMC6556884
  8. Jang, TL, Patel, N, Faiena, I, Radadia, KD, Moore, DF, Elsamra, SE, Singer, EA, Stein, MN, Eastham, JA, Scardino, PT et al.. Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer. Cancer. 2018;124 (20):4010-4022. doi: 10.1002/cncr.31726. PubMed PMID:30252932 PubMed Central PMC6234085
  9. Ferrari, AC, Alumkal, JJ, Stein, MN, Taplin, ME, Babb, J, Barnett, ES, Gomez-Pinillos, A, Liu, X, Moore, D, DiPaola, R et al.. Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer. Clin. Cancer Res. 2019;25 (1):52-63. doi: 10.1158/1078-0432.CCR-18-1589. PubMed PMID:30224345
  10. Yu, X, Kogan, S, Chen, Y, Tsang, AT, Withers, T, Lin, H, Gilleran, J, Buckley, B, Moore, D, Bertino, J et al.. Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics. Clin. Cancer Res. 2018;24 (18):4505-4517. doi: 10.1158/1078-0432.CCR-18-0822. PubMed PMID:29914895 PubMed Central PMC6139040
Search PubMed
Categories: Faculty, Environmental Epidemiology and Statistics
Skip to toolbar